Companies / DA32 Life Science Tech Acquisition Corp.
DA32 Life Science Tech Acquisition Corp.
DALSCIK 1863294
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jul 30, 2021 | Deerfield Management Co +2 co-filers Director | Buy Open-market buy | Class A Common Stock | $16.00M | +1.6M | 1,600,000 | high |
| Jul 30, 2021 | Section 32 Fund 3, LP Director | Buy Open-market buy | Class A Common Stock | $8.00M | +800K | 800,000 | high |
| Jul 30, 2021 | Section 32 Fund 3, LP Director | Grant Grant or award | Class A Common Stock | $6.50M | +650K +81.25% | 1,450,000 | low |
| Jul 30, 2021 | ARCH Venture Fund XI, L.P. 10% owner | Other Other (per filing) | Class A Common Stock | $6.50M | +650K +40.63% | 2,250,000 | low |
| Jul 30, 2021 | Deerfield Management Co +1 co-filer Director | Grant Grant or award | Class A Common Stock | $6.50M | +650K +40.63% | 2,250,000 | low |
| Jul 30, 2021 | DA32 Sponsor LLC 10% owner | Buy Open-market buy | Class A Common Stock | $6.50M | +650K | 650,000 | high |
| Aug 5, 2021 | Section 32 Fund 3, LP Director | Other Sold to issuer | Class B Common Stock, par value $0.0001 per share | — | -30K -0.64% | 4,665,000 | low |
| Aug 5, 2021 | Section 32 Fund 3, LP Director | Other Sold to issuer | Class B Common Stock, par value $0.0001 per share | — | -701K -13.00% | 4,695,000 | low |